Could a simple drug tame surgery inflammation in colon cancer patients?
NCT ID NCT06272461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving lidocaine or ketamine during colorectal cancer surgery can lower inflammation (measured by a substance called IL-6) and help patients feel better after the operation. About 50 adults having open colorectal surgery will receive one of the two drugs for 24 hours. The goal is to see which drug reduces pain, nausea, and helps the bowel work again sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL (COLON OR RECTAL) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tunisia
RECRUITINGNabeul, 8000, Tunisia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Grape powder may help aging immune systems — a trial puts it to the test
- A simple blood pressure cuff trick could shield the heart in kidney disease
- Can a sedative help rebuilt tissue survive after cancer surgery?
- Laser light may soothe brace pain without drugs